Intrinsic Value of S&P & Nasdaq Contact Us

Glaukos Corporation GKOS NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$143.44
+18.5%

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

Metric Latest Quarter (2025-12)
Total Assets $893.49M
Total Liabilities $237.33M
Total Debt $139.64M
Cash & Investments $278.76M
Total Stockholders Equity $656.16M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message